ACAD Antibodies

"ACAD" typically refers to genes that encode acyl-CoA dehydrogenases. Acyl-CoA dehydrogenases are a group of enzymes involved in fatty acid metabolism, specifically in the breakdown of fatty acids for energy production. These enzymes catalyze the initial step of beta-oxidation, a process in which fatty acids are broken down into acetyl-CoA, which can then enter the citric acid cycle for energy production.

There are several ACAD genes, each encoding a specific acyl-CoA dehydrogenase enzyme with preferences for different lengths of fatty acid chains. For example:

ACADVL (Very Long-Chain Acyl-CoA Dehydrogenase): Mutations in this gene are associated with very-long-chain acyl-CoA dehydrogenase deficiency, which is a rare inherited disorder affecting fatty acid metabolism.

ACADS (Short-Chain Acyl-CoA Dehydrogenase): Mutations in this gene can lead to short-chain acyl-CoA dehydrogenase deficiency, another inherited metabolic disorder.

ACADM (Medium-Chain Acyl-CoA Dehydrogenase): Mutations in this gene can cause medium-chain acyl-CoA dehydrogenase deficiency, which is one of the most common fatty acid oxidation disorders.

ACAD9 (Acyl-CoA Dehydrogenase 9): Mutations in this gene are associated with a mitochondrial complex I deficiency and myopathic form of mitochondrial DNA depletion syndrome.

These genes play crucial roles in maintaining energy balance and are essential for normal cellular function. Mutations in ACAD genes can lead to various metabolic disorders, emphasizing the importance of these genes in human health.